163 related articles for article (PubMed ID: 3333272)
21. Thymidine kinase activity and trifluorothymidine resistance of spontaneous and mutagen-induced L5178Y cells in RPMI 1640 medium.
Oberly TJ; Bewsey BJ; Probst GS
Mutat Res; 1986 Jul; 161(2):165-71. PubMed ID: 3088439
[TBL] [Abstract][Full Text] [Related]
22. The critical influence of temperature upon trifluorothymidine resistance in mouse lymphoma L5178Y/TK 3.7.2C cells.
Amacher DE; Turner GN
Mutat Res; 1989 Dec; 224(4):415-26. PubMed ID: 2479834
[TBL] [Abstract][Full Text] [Related]
23. Mutagenicity and clastogenicity of adriamycin in L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
Moore MM; Brock KH; Doerr CL; DeMarini DM
Mutat Res; 1987; 191(3-4):183-8. PubMed ID: 3627155
[TBL] [Abstract][Full Text] [Related]
24. Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk +/-) locus of mouse lymphoma assay.
Clive D; Turner N; Krehl R
Mutagenesis; 1988 Mar; 3(2):83-7. PubMed ID: 3288842
[TBL] [Abstract][Full Text] [Related]
25. The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK-/-) mutants from L5178Y/TK+/- mouse lymphoma cells.
Moore-Brown MM; Clive D; Howard BE; Batson AG; Johnson KO
Mutat Res; 1981 Oct; 85(5):363-78. PubMed ID: 6795499
[TBL] [Abstract][Full Text] [Related]
26. High-resolution cytogenetic characterization of the L5178Y TK+/- mouse lymphoma cell line.
Sawyer JR; Moore MM; Hozier JC
Mutat Res; 1989 Oct; 214(2):181-93. PubMed ID: 2797024
[TBL] [Abstract][Full Text] [Related]
27. A statistical method for analysis of mouse lymphoma L5178Y cell TK locus forward mutation assay. Comparison of results among three laboratories.
Irr JD; Snee RD
Mutat Res; 1982 Oct; 97(5):371-92. PubMed ID: 7144804
[TBL] [Abstract][Full Text] [Related]
28. Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds.
Wangenheim J; Bolcsfoldi G
Mutagenesis; 1988 May; 3(3):193-205. PubMed ID: 3045481
[TBL] [Abstract][Full Text] [Related]
29. Comparative mutagenicity of hydrazine and 3 methylated derivatives in L5178Y mouse lymphoma cells.
Rogers AM; Back KC
Mutat Res; 1981 Aug; 89(4):321-8. PubMed ID: 7290098
[TBL] [Abstract][Full Text] [Related]
30. Stability of tk-/- mutants of L5178Y mouse lymphoma cells in Fischer's medium.
Clive D; Krehl R
Mutat Res; 1991 Aug; 260(4):409-13. PubMed ID: 1908056
[TBL] [Abstract][Full Text] [Related]
31. Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells.
Applegate ML; Moore MM; Broder CB; Burrell A; Juhn G; Kasweck KL; Lin PF; Wadhams A; Hozier JC
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):51-5. PubMed ID: 1967496
[TBL] [Abstract][Full Text] [Related]
32. Ascorbate is detectably mutagenic in the L5178Y TK+/- cell mutation assay.
Amacher DE; Paillet SC
Cancer Lett; 1981 Nov; 14(2):151-8. PubMed ID: 7317878
[TBL] [Abstract][Full Text] [Related]
33. Evidence for indirect involvement of thymidine kinase in excision repair processes in mouse cell lines.
McKenna PG; Yasseen AA; McKelvey VJ
Somat Cell Mol Genet; 1985 May; 11(3):239-46. PubMed ID: 3859020
[TBL] [Abstract][Full Text] [Related]
34. High-resolution cytogenetic analysis of L5178Y TK+/- 3.7.2C cells: variation in chromosome 11 breakpoints among small-colony TK-/- mutants.
Hozier JC; Sawyer JR; Moore MM
Mutat Res; 1989 Oct; 214(2):195-9. PubMed ID: 2797025
[TBL] [Abstract][Full Text] [Related]
35. Comparative mutagenicity of 4 DNA-intercalating agents in L5178Y mouse lymphoma cells.
Rogers AM; Back KC
Mutat Res; 1982 Dec; 102(4):447-55. PubMed ID: 7177152
[TBL] [Abstract][Full Text] [Related]
36. Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/- mouse lymphoma cells.
Moore MM; Clive D; Hozier JC; Howard BE; Batson AG; Turner NT; Sawyer J
Mutat Res; 1985 Aug; 151(1):161-74. PubMed ID: 3927157
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of ouabain-resistant mutants of the mouse lymphoma cell line L5178Y.
Muriel WJ; Cole J; Lehmann AR
Mutagenesis; 1987 Sep; 2(5):383-9. PubMed ID: 2830454
[TBL] [Abstract][Full Text] [Related]
38. The induction and characterization of mouse lymphoma L5178Y cell lines resistant to 1-beta-d-arabinofuranosylcytosine.
Rogers AM; Hill R; Lehmann AR; Arlett CF; Burns VW
Mutat Res; 1980 Jan; 69(1):139-48. PubMed ID: 7360142
[TBL] [Abstract][Full Text] [Related]
39. Mutagenicity testing in mammalian cells. II. Validation of multiple drug-resistance markers having practical application for screening potential mutagens.
Carver JH; Adair GM; Wandres DL
Mutat Res; 1980 Sep; 72(2):207-30. PubMed ID: 6449664
[TBL] [Abstract][Full Text] [Related]
40. Hamster hepatocyte-mediated activation of procarcinogens to mutagens in the L5178Y/TK mutation assay.
Amacher DE; Paillet SC
Mutat Res; 1982 Dec; 106(2):305-16. PubMed ID: 7155171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
